Zhou AP - Search Results

1

Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as postoperative treatment for stage II and III rectal cancer.

Jin J, Li YX, Wang JW, Wang WH, Liu YP, Wang K, Fang H, Zhou ZX, Zhou AP, Yu ZH. Jin J, et al. Among authors: zhou zx, zhou ap. Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):671-7. doi: 10.1016/j.ijrobp.2008.01.057. Epub 2008 May 1. Int J Radiat Oncol Biol Phys. 2008. PMID: 18455328 Clinical Trial.

2

[Tropisetron in attenuation of nausea and vomiting in patients undergoing high-dose chemo-radiotherapy supported by autologous peripheral blood stem cell transplantation].

He XH, Shi YK, Yang JL, Zhang CG, Liu P, Zhou AP, Zhou SY, Ai B. He XH, et al. Among authors: zhou sy, zhou ap. Ai Zheng. 2004 Apr;23(4):456-60. Ai Zheng. 2004. PMID: 15087039 Clinical Trial. Chinese.

3

[Safety of adjuvant dose-dense chemotherapy with paclitaxel and epirubicin for high-risk breast cancer].

Wu WH, Li Q, Xu BH, Zhang P, Zhao LM, Yuan P, Wang JY, Cai RG, Zhou AP. Wu WH, et al. Among authors: zhou ap. Zhonghua Zhong Liu Za Zhi. 2008 Jul;30(7):548-51. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19062727 Clinical Trial. Chinese.

4

[Phase II clinical trial of docetaxel, platinum and S-1 for advanced gastric cancer].

Zhou AP, Li YS, Yang L, Song Y, Sun YK, Zhang W, Cui CX, Chi Y, Yuan XH, Lü N, Wang JW. Zhou AP, et al. Zhonghua Yi Xue Za Zhi. 2012 Jun 26;92(24):1677-80. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22944157 Clinical Trial. Chinese.

5

[Neuroendocrine tumors: analysis of 252 cases].

Chi YH, Jiang WC, Du F, Sun YK, Song Y, Yang L, Zhou AP, Wang JW. Chi YH, et al. Among authors: zhou ap. Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):67-70. doi: 10.3760/cma.j.issn.0253-3766.2013.01.015. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23648305 Chinese.

6

[Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].

Qin Q, Yang L, Zhou AP, Sun YK, Song Y, DU F, Wang JW. Qin Q, et al. Among authors: zhou ap. Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):212-6. doi: 10.3760/cma.j.issn.0253-3766.2013.03.011. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23880003 Chinese.

7

A phase II trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer.

Yang L, Song Y, Zhou AP, Qin Q, Chi Y, Huang J, Wang JW. Yang L, et al. Among authors: zhou ap. Chin Med J (Engl). 2013;126(18):3470-4. Chin Med J (Engl). 2013. PMID: 24034092 Clinical Trial.

8

Phase I study of the safety, pharmacokinetics and antitumor activity of famitinib.

Zhou A, Zhang W, Chang C, Chen X, Zhong D, Qin Q, Lou D, Jiang H, Wang J. Zhou A, et al. Cancer Chemother Pharmacol. 2013 Nov;72(5):1043-53. doi: 10.1007/s00280-013-2282-y. Epub 2013 Sep 17. Cancer Chemother Pharmacol. 2013. PMID: 24043137 Clinical Trial.

9

Famitinib in metastatic renal cell carcinoma: a single center study.

Zhang W, Zhou AP, Qin Q, Chang CX, Jiang HY, Ma JH, Wang JW. Zhang W, et al. Among authors: zhou ap. Chin Med J (Engl). 2013 Nov;126(22):4277-81. Chin Med J (Engl). 2013. PMID: 24238512 Clinical Trial.

10

Dose-finding study on adjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancer.

Yang L, Yang Y, Qin Q, Zhou A, Zhao J, Wang J, Shu C, Yuan X, Hu S. Yang L, et al. Mol Clin Oncol. 2014 Jan;2(1):93-98. doi: 10.3892/mco.2013.191. Epub 2013 Sep 23. Mol Clin Oncol. 2014. PMID: 24649314 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters